Works matching IS 13479032 AND DT 2024 AND VI 115 AND IP 10

Results: 32

In this issue: Volume 115, Issue 10, October 2024.
Published in:
Cancer Science, 2024, v. 115, n. 10, p. 3205, doi. 10.1111/cas.16358
Publication type:
Article
Correction to "ELF3‐AS1 contributes to gastric cancer progression by binding to hnRNPK and induces thrombocytosis in peripheral blood".
Published in:
Cancer Science, 2024, v. 115, n. 10, p. 3497, doi. 10.1111/cas.16318
Publication type:
Article
A highly sensitive reporter system to monitor endogenous YAP1/TAZ activity and its application in various human cells.
Published in:
Cancer Science, 2024, v. 115, n. 10, p. 3370, doi. 10.1111/cas.16316
By:
- Hikasa, Hiroki;
- Kawahara, Kohichi;
- Inui, Masako;
- Yasuki, Yukichika;
- Yamashita, Keita;
- Otsubo, Kohei;
- Kitajima, Shojiro;
- Nishio, Miki;
- Arima, Kazunari;
- Endo, Motoyoshi;
- Taira, Masanori;
- Suzuki, Akira
Publication type:
Article
Fusobacterium nucleatum, immune responses, and metastatic organ diversity in colorectal cancer liver metastasis.
Published in:
Cancer Science, 2024, v. 115, n. 10, p. 3248, doi. 10.1111/cas.16315
By:
- Shigematsu, Yasuyuki;
- Saito, Rumiko;
- Amori, Gulanbar;
- Kanda, Hiroaki;
- Takahashi, Yu;
- Takeuchi, Kengo;
- Takahashi, Shunji;
- Inamura, Kentaro
Publication type:
Article
Unlocking Japan's cervical cancer prevention deadlock.
Published in:
Cancer Science, 2024, v. 115, n. 10, p. 3486, doi. 10.1111/cas.16311
By:
- Tjalma, Wiebren A. A.
Publication type:
Article
Delta‐6 desaturase FADS2 is a tumor‐promoting factor in cholangiocarcinoma.
Published in:
Cancer Science, 2024, v. 115, n. 10, p. 3346, doi. 10.1111/cas.16306
By:
- Hasegawa, Kohsei;
- Fujimori, Haruna;
- Nakatani, Kohta;
- Takahashi, Masatomo;
- Izumi, Yoshihiro;
- Bamba, Takeshi;
- Nakamura‐Shima, Mao;
- Shibuya‐Takahashi, Rie;
- Mochizuki, Mai;
- Wakui, Yuta;
- Abue, Makoto;
- Iwai, Wataru;
- Fukushi, Daisuke;
- Satoh, Kennichi;
- Yamaguchi, Kazunori;
- Shindo, Norihisa;
- Yasuda, Jun;
- Asano, Naoki;
- Imai, Takayuki;
- Asada, Yukinori
Publication type:
Article
RETRACTION: Capn4 is a Marker of Poor Clinical Outcomes and Promotes Nasopharyngeal Carcinoma Metastasis via Nuclear Factor‐κB‐Induced Matrix Metalloproteinase 2 Expression.
Published in:
Cancer Science, 2024, v. 115, n. 10, p. 3491, doi. 10.1111/cas.16305
Publication type:
Article
A multicenter study on deep learning for glioblastoma auto‐segmentation with prior knowledge in multimodal imaging.
Published in:
Cancer Science, 2024, v. 115, n. 10, p. 3415, doi. 10.1111/cas.16304
By:
- Tian, Suqing;
- Liu, Yinglong;
- Mao, Xinhui;
- Xu, Xin;
- He, Shumeng;
- Jia, Lecheng;
- Zhang, Wei;
- Peng, Peng;
- Wang, Junjie
Publication type:
Article
Concerning trends and potential issues in osteosarcoma research publication.
Published in:
Cancer Science, 2024, v. 115, n. 10, p. 3483, doi. 10.1111/cas.16303
By:
- Horiuchi, Keisuke;
- Chiba, Kazuhiro
Publication type:
Article
Correction to "P68 RNA helicase promotes invasion of glioma cells through negatively regulating DUSP5".
Published in:
Cancer Science, 2024, v. 115, n. 10, p. 3495, doi. 10.1111/cas.16301
Publication type:
Article
Multiplex plasma protein assays as a diagnostic tool for lung cancer.
Published in:
Cancer Science, 2024, v. 115, n. 10, p. 3439, doi. 10.1111/cas.16300
By:
- Ahamed, Mohammad Tanvir;
- Forshed, Jenny;
- Levitsky, Adrian;
- Lehtiö, Janne;
- Bajalan, Amanj;
- Pernemalm, Maria;
- Eriksson, Lars E.;
- Andersson, Björn
Publication type:
Article
Overcoming immunotherapy resistance and inducing abscopal effects with boron neutron immunotherapy (B‐NIT).
Published in:
Cancer Science, 2024, v. 115, n. 10, p. 3231, doi. 10.1111/cas.16298
By:
- Fujimoto, Takuya;
- Yamasaki, Osamu;
- Kanehira, Noriyuki;
- Matsushita, Hirokazu;
- Sakurai, Yoshinori;
- Kenmotsu, Naoya;
- Mizuta, Ryo;
- Kondo, Natsuko;
- Takata, Takushi;
- Kitamatsu, Mizuki;
- Igawa, Kazuyo;
- Fujimura, Atsushi;
- Otani, Yoshihiro;
- Shirakawa, Makoto;
- Shigeyasu, Kunitoshi;
- Teraishi, Fuminori;
- Togashi, Yosuke;
- Suzuki, Minoru;
- Fujiwara, Toshiyoshi;
- Michiue, Hiroyuki
Publication type:
Article
MGMT protein expression is a reliable predictive biomarker for temozolomide‐containing chemotherapy in osteosarcoma.
Published in:
Cancer Science, 2024, v. 115, n. 10, p. 3394, doi. 10.1111/cas.16297
By:
- Uchihara, Yoshinori;
- Umeda, Katsutsugu;
- Yamada, Yosuke;
- Ito, Hiroaki;
- Tasaka, Keiji;
- Isobe, Kiyotaka;
- Akazawa, Ryo;
- Kawabata, Naoko;
- Saida, Satoshi;
- Kato, Itaru;
- Hiramatsu, Hidefumi;
- Noguchi, Takashi;
- Sakamoto, Akio;
- Arakawa, Yoshiki;
- Arakawa, Ayumu;
- Yamamoto, Nobuyuki;
- Hosoya, Yosuke;
- Uemura, Suguru;
- Watanabe, Ken‐ichiro;
- Sano, Hideki
Publication type:
Article
N‐acetylgalactosaminyltransferase GALNT6 is a potential therapeutic target of clear cell renal cell carcinoma progression.
Published in:
Cancer Science, 2024, v. 115, n. 10, p. 3320, doi. 10.1111/cas.16296
By:
- Sun, Luhaoran;
- Li, Zeyu;
- Shu, Peng;
- Lu, Min
Publication type:
Article
Blocking CXCR4–CARM1–YAP axis overcomes osteosarcoma doxorubicin resistance by suppressing aerobic glycolysis.
Published in:
Cancer Science, 2024, v. 115, n. 10, p. 3305, doi. 10.1111/cas.16295
By:
- Li, Zihua;
- Lu, Hengli;
- Zhang, Yiwei;
- Lv, Jiyang;
- Zhang, Yi;
- Xu, Tianyang;
- Yang, Dong;
- Duan, Zhengwei;
- Guan, Yonghao;
- Jiang, Zongrui;
- Liu, Kaiyuan;
- Liao, Yuxin
Publication type:
Article
Which occurs first, ARID1A inactivation or microsatellite instability?: A comment to Yamamoto et al. (2024).
Published in:
Cancer Science, 2024, v. 115, n. 10, p. 3488, doi. 10.1111/cas.16294
By:
- Lee, Dakeun
Publication type:
Article
Initial AXL and MCL‐1 inhibition contributes to abolishing lazertinib tolerance in EGFR‐mutant lung cancer cells.
Published in:
Cancer Science, 2024, v. 115, n. 10, p. 3333, doi. 10.1111/cas.16292
By:
- Matsui, Yohei;
- Yamada, Tadaaki;
- Katayama, Yuki;
- Hirai, Soichi;
- Sawada, Ryo;
- Tachibana, Yusuke;
- Ishida, Masaki;
- Kawachi, Hayato;
- Nakamura, Ryota;
- Nishioka, Naoya;
- Morimoto, Kenji;
- Iwasaku, Masahiro;
- Horinaka, Mano;
- Sakai, Toshiyuki;
- Tokuda, Shinsaku;
- Takayama, Koichi
Publication type:
Article
Correction to inhibition of microRNA let‐7b expression by KDM2B promotes cancer progression by targeting EZH2 in ovarian cancer.
Published in:
Cancer Science, 2024, v. 115, n. 10, p. 3492, doi. 10.1111/cas.16291
Publication type:
Article
The molecular mechanism underlying KRAS regulation on STK31 expression in pancreatic ductal adenocarcinoma.
Published in:
Cancer Science, 2024, v. 115, n. 10, p. 3288, doi. 10.1111/cas.16286
By:
- Liu, Yuting;
- Tang, Shing Chun;
- Li, Chi Han;
- To, Ka Fai;
- Li, Bo;
- Chan, Stephen Lam;
- Wong, Chi Hin;
- Chen, Yangchao
Publication type:
Article
Plasma cell‐free DNA methylome‐based liquid biopsy for accurate gastric cancer detection.
Published in:
Cancer Science, 2024, v. 115, n. 10, p. 3426, doi. 10.1111/cas.16284
By:
- Qi, Jian;
- Hong, Bo;
- Wang, Shujie;
- Wang, Jingyun;
- Fang, Jinman;
- Sun, Ruifang;
- Nie, Jinfu;
- Wang, Hongzhi
Publication type:
Article
Tumor‐derived mitochondrial formyl peptides suppress tumor immunity through modification of the tumor microenvironment.
Published in:
Cancer Science, 2024, v. 115, n. 10, p. 3218, doi. 10.1111/cas.16266
By:
- Waki, Kayoko;
- Ozawa, Miyako;
- Ohta, Keisuke;
- Komatsu, Nobukazu;
- Yamada, Akira
Publication type:
Article
Spatial omics technologies for understanding molecular status associated with cancer progression.
Published in:
Cancer Science, 2024, v. 115, n. 10, p. 3208, doi. 10.1111/cas.16283
By:
- Nagasawa, Satoi;
- Zenkoh, Junko;
- Suzuki, Yutaka;
- Suzuki, Ayako
Publication type:
Article
Newly developed humanized anti‐CKAP4 antibody suppresses pancreatic cancer growth by inhibiting DKK1‐CKAP4 signaling.
Published in:
Cancer Science, 2024, v. 115, n. 10, p. 3358, doi. 10.1111/cas.16278
By:
- Sada, Ryota;
- Yamamoto, Hideki;
- Matsumoto, Shinji;
- Harada, Akikazu;
- Kikuchi, Akira
Publication type:
Article
Correction to: AC016405.3, a novel long noncoding RNA, acts as a tumor suppressor through modulation of TET2 by microRNA‐19a‐5p sponging in glioblastoma.
Published in:
Cancer Science, 2024, v. 115, n. 10, p. 3496, doi. 10.1111/cas.16277
Publication type:
Article
CLG promotes mTOR/ULK1 pathway‐mediated autophagy to inhibit OS development by inhibiting TRAF6‐mediated FLT3 ubiquitination.
Published in:
Cancer Science, 2024, v. 115, n. 10, p. 3466, doi. 10.1111/cas.16274
By:
- Huang, Xiongjie;
- Huang, Yanran;
- Peng, Bin;
- Wang, Junfang;
- Tang, Huiyu;
- Chen, Yanming
Publication type:
Article
Unveiling hierarchy and spatial distribution of O<sup>6</sup>‐methylguanine‐DNA methyltransferase promoter methylation in World Health Organization grade 2–3 gliomas.
Published in:
Cancer Science, 2024, v. 115, n. 10, p. 3403, doi. 10.1111/cas.16268
By:
- Li, Mingxiao;
- Liu, Jiang;
- Weng, Jiancong;
- Dong, Gehong;
- Chen, Xuzhu;
- Cui, Yong;
- Ren, Xiaohui;
- Shen, Shaoping;
- Jiang, Haihui;
- Zhang, Xiaokang;
- Zhao, Xuzhe;
- Li, Ming;
- Wang, Xijie;
- Ren, Hongxiang;
- Li, Qiang;
- Zhang, Yulian;
- Cheng, Quan;
- Yu, Yanbing;
- Lin, Song
Publication type:
Article
Interim PET‐guided ABVD or ABVD/escalated BEACOPP for newly diagnosed advanced‐stage classic Hodgkin lymphoma (JCOG1305).
Published in:
Cancer Science, 2024, v. 115, n. 10, p. 3384, doi. 10.1111/cas.16281
By:
- Kusumoto, Shigeru;
- Munakata, Wataru;
- Machida, Ryunosuke;
- Terauchi, Takashi;
- Onaya, Hiroaki;
- Oguchi, Masahiko;
- Iida, Shinsuke;
- Nosaka, Kisato;
- Suzuki, Yasuhiro;
- Harada, Yasuhiko;
- Miyazaki, Kana;
- Maruta, Masaki;
- Fukuhara, Noriko;
- Toubai, Tomomi;
- Kubota, Nobuko;
- Ohmachi, Ken;
- Saito, Toko;
- Rai, Shinya;
- Mizuno, Ishikazu;
- Fukuhara, Suguru
Publication type:
Article
CircMAN1A2_009 facilitates YBX1 nuclear localization to induce GLO1 activation for cervical adenocarcinoma cell growth.
Published in:
Cancer Science, 2024, v. 115, n. 10, p. 3273, doi. 10.1111/cas.16264
By:
- Huang, Yongjie;
- Wei, Xinyi;
- Tu, Mengyan;
- Lu, Weiguo;
- Xu, Junfen
Publication type:
Article
Clinicopathological, molecular, and prognostic features of colorectal carcinomas with KRAS c.34G>T (p.G12C) mutation.
Published in:
Cancer Science, 2024, v. 115, n. 10, p. 3455, doi. 10.1111/cas.16262
By:
- Ugai, Satoko;
- Yao, Qian;
- Takashima, Yasutoshi;
- Zhong, Yuxue;
- Matsuda, Kosuke;
- Kawamura, Hidetaka;
- Imamura, Yu;
- Okadome, Kazuo;
- Mima, Kosuke;
- Arima, Kota;
- Kosumi, Keisuke;
- Song, Mingyang;
- Meyerhardt, Jeffrey A.;
- Giannakis, Marios;
- Nowak, Jonathan A.;
- Ugai, Tomotaka;
- Ogino, Shuji
Publication type:
Article
NAT10 inhibition promotes ac4C‐dependent ferroptosis to counteract sorafenib resistance in nasopharyngeal carcinoma.
Published in:
Cancer Science, 2024, v. 115, n. 10, p. 3256, doi. 10.1111/cas.16249
By:
- Xue, Ziyi;
- Xie, Haijing;
- Shan, Ying;
- Zhang, Lin;
- Cheng, Lin;
- Chen, Wenyue;
- Zhu, Rui;
- Zhang, Kaiwen;
- Ni, Haosheng;
- Zhang, Zhenxin;
- You, Yiwen;
- You, Bo
Publication type:
Article
Accurate predictors of immune checkpoint inhibitors in patients with gallbladder cancer.
Published in:
Cancer Science, 2024, v. 115, n. 10, p. 3481, doi. 10.1111/cas.16235
By:
- Li, Naimei;
- Deng, Shuang
Publication type:
Article
Issue Information.
Published in:
Cancer Science, 2024, v. 115, n. 10, p. 3201, doi. 10.1111/cas.15866
Publication type:
Article